AdaptVac Company
AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
Hørsholm, Hovedstaden, Denmark
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
N/A
Investors Number:
1
Total Funding:
119126
Last Funding Date:
2019-10-17
Last Funding Type:
Grant
Register and Claim Ownership